Technology Developments in Functional Proteomics (Technical Insights)


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

Outlines global innovation and technology development in the field of functional proteomics.

Table of Contents

Technology Developments in Functional Proteomics (Technical Insights), Executive SummaryIntroductionIntroductionNoteworthy ApplicationsMarket TrendsNoteworthy Emerging TechnologiesScope and MethodologyScopeMethodologyTechnology Developments in Functional Proteomics (Technical Insights), Technology and Applications Viewpoint Technology Primer--Proteomics TechnologiesProteomics Techniques--GeneralProteomic Techniques--Functional ProteomicsFunctional Proteomic ApproachesAdditional ApproachesApplications Analysis and TrendsAntibodies as TherapeuticsTechnology Developments in Functional Proteomics (Technical Insights), Technology Impact AnalysisAssessment of Stakeholder Innovation and Technology Transfer OpportunitiesIntroductionNoteworthy Innovation at Key CompaniesNoteworthy Innovation at Key Academic and Government-Related InstitutionsInfluential Market Factors and Industry TrendsMergers & Acquisition ActivityRegulatory and Political or Other FactorsIndustry TrendsTechnology Developments in Functional Proteomics (Technical Insights), Technology Adoption Factor AnalysisPrimary ChallengesTechnology or Product Development RestraintsCompeting TechnologiesAnalysis of Market DriversAnalysis of Funding SourcesFeatures and Advantages of Functional ProteomicsEnabling TechnologiesAdoption Drivers for Functional ProteomicsTechnology Developments in Functional Proteomics (Technical Insights), Assessment of Innovation and Opportunities Assessment of Innovation in North America--CompaniesPhosphoprotein Profiling Platform I.D. Cancer-Drug TargetIn Vitro Molecular Imaging Tool Directly Images Protein BiomarkersProteinChip Chromatographic Array System Relates Proteins to DiseaseMicroarrays and Gold Balls I.D. Proteins Better than ELISAHigh-Content ScreeningTWEAK Pathway Plays Role in ArthritisTyrosine Kinase Mutant Associated with AMLRecombinant Proteins with Human Glycosylation From YeastAdditional CompaniesAssessment of Innovation in North America--Government and Academic Research InstitutionsMulticolor Color BiFC Assays Developed by Purdue UniversityNature’s Most Resilient NanospringsBiosensor Dye Aid Viewing Proteins in Live CellsLab-On-Chip Analyzes One Cell at a TimeLinking Enzyme Sequence to FunctionSecond Function Found for Cell-Cycle Regulatory ProteinMitochondrial Protein Also Helps Cells Fend off VirusesModified E. Coli Make Human GlycoproteinsSignalling Protein Acts in Nucleus; Not Just in CytoplasmSMS Nanoprobe Could Lead to Better Diagnosis; Drug DesignAssessment of Innovation in EuropeCompaniesAdditional CompaniesGovernment and Academic Research InstitutionsAssessment of Innovation in the Asia Pacific RegionCompaniesGovernment and Academic Research InstitutionsTechnology Developments in Functional Proteomics (Technical Insights), Patents and ContactsPatentsPatentsContactsContactsTechnology Developments in Functional Proteomics (Technical Insights), Decision Support DatabaseR&D ExpenditurePharmaceutical R&D Expenditure--World (2002 to 2012)Percentage of Pharmaceutical R&D Expenditure--World (2002 to 2012)Biotechnology InvestmentGovernment Investment in Biotech R&D--World (2002 to 2012)Venture Capital Investment in Biotech R&D--World (2002 to 2012)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.